This document provides information on cerebral palsy, including its definition, causes, classifications, clinical features, complications, investigations, management, and rehabilitation. Cerebral palsy is defined as a static encephalopathy caused by an insult to the developing brain before age 2 that results in motor and/or posture handicaps. It is classified based on etiology, topography, physiology, and functional ability. Spastic cerebral palsy is the most common type. Management involves a multidisciplinary rehabilitation approach including medications, nutrition, physical, occupational, speech, and dental therapies, and surgery if needed. The goals of rehabilitation are to improve functions, develop compensatory abilities, and maximize independence.
This document provides an overview of cerebral palsy (CP), including:
- CP is a permanent disorder of movement and posture caused by non-progressive brain damage early in development. It causes limitations in activity.
- CP is classified based on physiology (type of abnormal muscle tone), topography (location of affected limbs), and etiology (underlying cause). The most common types are spastic diplegia and spastic hemiplegia.
- CP is diagnosed based on clinical features like abnormal muscle tone and reflexes. Comorbidities include seizures, intellectual disabilities, and secondary musculoskeletal problems. Timely diagnosis and treatment can help improve prognosis and prevent further complications.
Cerebral palsy is a non-progressive disorder affecting movement and posture, often with associated epilepsy, vision, speech, and intellectual impairments, resulting from brain lesions or defects during development. It is the most common motor disability in childhood, affecting 2-2.5 per 1,000 children in the US. Causes include prematurity, genetic factors, infections, and brain injuries during prenatal, perinatal, or postnatal periods. Common types are spastic diplegia, hemiplegia, and quadriplegia. Diagnosis involves assessing abnormal movements, tone, reflexes and ruling out other causes through history and examination.
This document defines cerebral palsy as a group of disorders affecting movement and posture due to non-progressive disturbances in the developing fetal or infant brain. It can cause varying degrees of impairment ranging from minor to severe. The causes are often prenatal factors like infection or placental problems. Cerebral palsy is classified based on physiology (spastic or non-spastic types) and site of involvement (hemiplegia, diplegia, quadriplegia). Management is multidisciplinary and aims to improve function and quality of life through therapies, orthopedic interventions, medications and surgery. Prevention focuses on reducing maternal and neonatal insults that can cause brain damage.
Cerebral palsy (CP) is a group of disorders that affect movement and posture, caused by non-progressive brain damage early in development. It is characterized by abnormal muscle tone or movement, and often accompanied by disturbances of sensation, perception, cognition, communication, and behavior. CP can be caused by various genetic and acquired factors that result in brain abnormalities before, during, or after birth. While historically considered static, some features of CP may change over time. Treatment requires a multidisciplinary approach to manage symptoms, prevent complications, and improve function through therapies, medications, surgery, and equipment.
Cerebral palsy (CP) is the most common motor disability in childhood. It is caused by a non-progressive brain injury early in development. CP is characterized by disorders of movement and posture that limit activity. The document discusses the definition, epidemiology, classification, diagnosis, treatment, and management of CP. A multidisciplinary approach is needed to address the motor and associated disabilities of CP.
This document provides information on cerebral palsy (CP), including its definition, causes, classifications, clinical manifestations, diagnosis and treatment. CP is a permanent motor disability caused by brain insult during development. It is classified based on affected motor function and includes spastic diplegia, quadriplegia and hemiplegia. Treatment involves a multidisciplinary team to address motor impairments, prevent complications, and support normal development through therapies and adaptive equipment.
This document provides an overview of cerebral palsy (CP), including:
- CP is a permanent disorder of movement and posture caused by non-progressive brain damage early in development. It causes limitations in activity.
- CP is classified based on physiology (type of abnormal muscle tone), topography (location of affected limbs), and etiology (underlying cause). The most common types are spastic diplegia and spastic hemiplegia.
- CP is diagnosed based on clinical features like abnormal muscle tone and reflexes. Comorbidities include seizures, intellectual disabilities, and secondary musculoskeletal problems. Timely diagnosis and treatment can help improve prognosis and prevent further complications.
Cerebral palsy is a non-progressive disorder affecting movement and posture, often with associated epilepsy, vision, speech, and intellectual impairments, resulting from brain lesions or defects during development. It is the most common motor disability in childhood, affecting 2-2.5 per 1,000 children in the US. Causes include prematurity, genetic factors, infections, and brain injuries during prenatal, perinatal, or postnatal periods. Common types are spastic diplegia, hemiplegia, and quadriplegia. Diagnosis involves assessing abnormal movements, tone, reflexes and ruling out other causes through history and examination.
This document defines cerebral palsy as a group of disorders affecting movement and posture due to non-progressive disturbances in the developing fetal or infant brain. It can cause varying degrees of impairment ranging from minor to severe. The causes are often prenatal factors like infection or placental problems. Cerebral palsy is classified based on physiology (spastic or non-spastic types) and site of involvement (hemiplegia, diplegia, quadriplegia). Management is multidisciplinary and aims to improve function and quality of life through therapies, orthopedic interventions, medications and surgery. Prevention focuses on reducing maternal and neonatal insults that can cause brain damage.
Cerebral palsy (CP) is a group of disorders that affect movement and posture, caused by non-progressive brain damage early in development. It is characterized by abnormal muscle tone or movement, and often accompanied by disturbances of sensation, perception, cognition, communication, and behavior. CP can be caused by various genetic and acquired factors that result in brain abnormalities before, during, or after birth. While historically considered static, some features of CP may change over time. Treatment requires a multidisciplinary approach to manage symptoms, prevent complications, and improve function through therapies, medications, surgery, and equipment.
Cerebral palsy (CP) is the most common motor disability in childhood. It is caused by a non-progressive brain injury early in development. CP is characterized by disorders of movement and posture that limit activity. The document discusses the definition, epidemiology, classification, diagnosis, treatment, and management of CP. A multidisciplinary approach is needed to address the motor and associated disabilities of CP.
This document provides information on cerebral palsy (CP), including its definition, causes, classifications, clinical manifestations, diagnosis and treatment. CP is a permanent motor disability caused by brain insult during development. It is classified based on affected motor function and includes spastic diplegia, quadriplegia and hemiplegia. Treatment involves a multidisciplinary team to address motor impairments, prevent complications, and support normal development through therapies and adaptive equipment.
Cerebral palsy is a condition caused by injury to the brain before, during, or after birth that affects muscle movement and coordination. It is the most common physical disability in childhood. The signs and symptoms vary depending on the type and severity but may include difficulties with movement, muscle tone issues, seizures, cognitive impairments, and more. The types are spastic, ataxic, athetoid/dyskinetic, and mixed. Treatment focuses on managing symptoms through therapies, medications, surgery, and assistive devices. Prevention emphasizes prenatal care, immunizations, and neonatal care and resuscitation.
This document provides information about cerebral palsy, including:
(1) It is a motor function disorder caused by permanent brain damage present at birth or shortly after.
(2) The most common types are spastic cerebral palsy (stiff muscles) and athetoid cerebral palsy (uncontrolled movements).
(3) Treatment aims to improve symptoms through physical therapy, bracing, medication, botulinum toxin injections, and sometimes surgery. The goal is improving quality of life and function rather than curing the underlying brain damage.
Outline of presentation
Introduction
Epidemiology
Etiology
Clinical manifestations
Diagnosis
Treatment
INTRODUCTION
Cerebral palsy (CP) refers to a heterogeneous group of conditions involving permanent nonprogressive central motor dysfunction that affect muscle tone, posture, and movement.
These conditions are due to abnormalities of the developing fetal or infantile brain resulting from a variety of causes.
The motor impairment generally results in limitations in functional abilities and activity which can range in severity.
The motor disorders are often accompanied by disturbances of sensation , perception, cognition, communication, and behavior as well as by epilepsy and secondary musculoskeletal problems.
CP has historically been considered a static encephalopathy, but some of the neurologicfeatures of CP, such as movement disorders and orthopedic complications can change or progress over time.
Many children and adults with CP function at a high educational and vocational level,without any sign of cognitive dysfunction
Etiology
CP is caused by a broad group of
Developmental,
Genetic,
Metabolic,
Ischemic,
Infectious, and
Other acquired etiologies
Epidemiology
CP is the most common and costly form of chronic motor disability that begins in childhood
Incidence is 3.6 per 1,000 children with a male: female ratio of 1.4 : 1.
Most children with CP had been born at term with uncomplicated labors anddeliveries
Risk factors
Prematurity and VLBW
Heavy maternal alcohol consumption,
Maternal smoking,
Maternal obesity, and
Infections during pregnancy
In 80% of cases, features were identified pointing to antenatal factors causing abnormal brain development
Fewer than 10% of children with CP had evidence of intrapartum asphyxia
Intrauterine exposure to maternal infection (chorioamnionitis, urinary tract infection) was associated with a significant increase in the risk of CP in normal birthweight infants.
Multiple pregnancy was also associated with a higher incidence of CP
Death of a twin in utero carries an even greater risk of CP
Infertility treatments are also associated with a higher rate of CP
CP is more common and more severe in boys than girls, and this effect is enhanced at the extremes of body weight
Elevated levels of inflammatory cytokines have been reported in heelstick blood collected at birth from children who later were identified with CP.
The prevalence of CP has increased somewhat as a result of the enhanced survival of very premature infants weighing < 1,000 g, who go on to develop CP at a rate of ~ 15 per 100.
However, the GA at birth adjusted prevalence of CP among 2 yr old former premature infants born at 20-27 wk of gestation has decreased over the past decade
The major lesions that contribute to CP in preterm infants are intracerebral hemorrhage and periventricular leukomalacia (PVL).
Neural tube defects are birth defects that result from the failure of the neural tube to close properly during early embryonic development. The most common types are spina bifida, anencephaly, and encephalocele. Prevention focuses on women getting adequate folic acid before and during early pregnancy. Treatment depends on the specific type of defect but may involve surgery to repair the opening and protect the exposed tissues, management of any related conditions like hydrocephalus, and lifelong care for resulting physical, neurological, and functional impairments. Prognosis depends on the severity of the defect and can include permanent disability.
Cerebral palsy assessment and management (PT) case presentation Meet Desai
The document discusses cerebral palsy, its causes, types, and treatment. It defines cerebral palsy as a motor disorder caused by brain damage early in development. The main causes are prenatal (e.g. brain malformations), perinatal (e.g. asphyxia during birth), and postnatal (e.g. infections). The physiotherapy management of cerebral palsy aims to improve mobility and function through techniques like passive stretching, strengthening exercises, and gait training. Treatment is multidisciplinary, involving physicians, surgeons, therapists and other specialists.
Common neonatal disorders include birth injuries, physiological problems, and respiratory, sepsis, and seizure issues. Birth injuries can involve soft tissue, the head, or nerves. Physiological problems include hyperbilirubinemia, hypoglycemia, hypocalcemia, and hypothermia. Respiratory disorders include respiratory distress syndrome and meconium aspiration syndrome. Neonatal jaundice is usually physiological but can also be pathological, breastfeeding-related, or due to breast milk. It is assessed and managed through history, examination, tests, phototherapy or admission based on bilirubin levels.
Cerebral palsy is a non-progressive brain disorder that causes impaired movement and posture. It is caused by damage to the developing brain, most often before or during birth. The document discusses the definition, prevalence, causes, classifications, clinical presentation, treatments, and management of cerebral palsy. It notes that cerebral palsy affects movement, mobility, communication, learning, self-care and more. Treatment involves a multidisciplinary team approach including physicians, physical therapists, occupational therapists and others.
The document contains summaries of 20 OSCE pediatric stations including questions on Down syndrome with esophageal atresia, typhoid vaccination recommendations, hemoglobin disorders, muscular dystrophies, transverse myelitis, Ehlers Danlos syndrome, pulmonary sequestration, Reiter's syndrome, enterobiasis, cleidocranial dysplasia, Wilson's disease, spinal cord injuries, Meckel's scan, congenital hypothyroidism, hemophilia A, neurocysticercosis and their diagnoses and management. The stations cover ethics, clinical examination, choice of investigations, interpretations of tests and forming differential diagnoses.
Cerebral palsy is a motor function disorder caused by a permanent, non-progressive brain lesion that is present at birth or shortly thereafter. It is characterized by impaired muscle coordination and tone. The main types are spastic, athetoid, ataxic, and mixed cerebral palsy. Treatment focuses on rehabilitation, physical therapy, surgery, and assistive devices to improve mobility and function rather than treating the underlying brain damage. The goals are to maximize independence and quality of life.
Cerebra palsy Management - Dr. Ramya -Pediatricspediatricsmgmcri
This document provides an overview of cerebral palsy (CP), including its definition as a non-progressive disorder caused by brain lesions or abnormalities that causes impaired movement and posture. It discusses the history of CP and risk factors like prematurity. The most common type is spastic CP, which can affect limbs differently. Associated problems include intellectual impairment, seizures, feeding and respiratory issues. Diagnosis involves assessing symptoms and medical history. Treatment involves physical, occupational and speech therapy, orthotics, surgery and medications to manage symptoms, along with special education and supportive services.
Cerebral palsy (CP) is divided into four major classifications: spastic, ataxic, dyskinetic, and mixed. The most common type is spastic CP, which is caused by damage to the pyramidal region and results in hypertonia, increased reflexes, and an abnormal gait. CP can be caused prenatally by factors like prematurity or infection, perinatally by hypoxic ischemic encephalopathy or kernicterus, or postnatally by infection or trauma. Diagnosis involves assessing for signs of abnormal muscle tone and movement, as well as investigations like brain imaging. Treatment requires a multidisciplinary approach including management of spasticity, associated issues like seizures
approach to a child with altered sensorium.pptxdrgsvt
The document provides guidance on assessing and managing an altered sensorium in a child. It describes stabilizing the child's airway, breathing, and circulation. It also recommends treating potential causes like hypoglycemia, infections, seizures and raised intracranial pressure. The primary goals are saving the child's life and achieving intact neurological recovery through a multidisciplinary approach.
Cerebral palsy is a permanent neurological disorder caused by non-progressive brain damage early in life. It affects movement and posture. The incidence is about 2 per 1000 live births in developed countries and 7 per 1000 in developing countries. Causes include complications during pregnancy, birth injuries, infections, and genetic factors. Treatment is non-curative and aims to improve function through a multidisciplinary approach including physiotherapy, orthopedic management, medications, assistive devices, and early intervention. Prognosis depends on the type and severity of symptoms present.
Cerebral palsy (CP) is a group of disorders caused by damage to the developing brain either during pregnancy or shortly after birth. It affects movement and posture and can cause physical disability. The main types are spastic CP (stiff muscles), athetoid/dyskinetic CP (uncontrolled movements), and ataxic CP (problems with coordination). Risk factors include preterm birth, low birth weight, infections during pregnancy, complications during delivery, and genetic disorders. Diagnosis involves assessing motor skills, muscle tone, reflexes, and ruling out other potential causes through imaging and tests.
Spinal tuberculosis can lead to serious deformities and neurological deficits if left untreated. It is most commonly caused by hematogenous spread from the lungs. Diagnosis involves clinical history, imaging studies like x-rays and MRI, and laboratory tests. Treatment consists of a combination of chemotherapy for at least 18 months and surgery if indicated to decompress the spinal cord and correct deformities. With early detection and proper management, spinal tuberculosis can be cured with good long-term outcomes.
Cerebral palsy is defined as a group of non-progressive motor impairment syndromes caused by abnormalities in movement, posture and tone. It has various etiologies including prenatal, perinatal and postnatal factors. It is classified based on the type of motor dysfunction into spastic, dyskinetic, hypotonic and ataxic. Diagnosis involves assessing abnormal signs and developmental milestones. Management is multidisciplinary and aims to minimize disability through rehabilitation therapies, prevention of contractures, drug treatments and assistive devices.
This document contains summaries of several pediatric endocrinology case studies presented as multiple choice questions. It discusses the following key points in 3 sentences:
1) A case of a 7-year-old girl with short stature is presented, and bone age assessment is identified as the most appropriate initial diagnostic investigation.
2) An 18-month-old boy with increasing bowing of the legs is described, and Blount's disease, which causes inward bowing of the tibia, is identified as the most likely diagnosis based on the presented x-ray findings.
3) An 8-week-old infant with fractures during birth and eye changes is discussed, and osteogenesis imperfecta, which
The neonatal period involves physiologic adjustments outside the womb. Seizures are common during this time, especially in preterm infants. There are 5 main types of neonatal seizures. Common causes include hypoxic-ischemic encephalopathy, infection, metabolic disturbances, and drugs. Treatment involves identifying the underlying cause, administering anticonvulsants like phenobarbital, and supportive care. Prognosis depends on the etiology, with HIE carrying the highest risk of neurodevelopmental issues.
Cerebral palsy is a condition caused by injury to the brain before, during, or after birth that affects muscle movement and coordination. It is the most common physical disability in childhood. The signs and symptoms vary depending on the type and severity but may include difficulties with movement, muscle tone issues, seizures, cognitive impairments, and more. The types are spastic, ataxic, athetoid/dyskinetic, and mixed. Treatment focuses on managing symptoms through therapies, medications, surgery, and assistive devices. Prevention emphasizes prenatal care, immunizations, and neonatal care and resuscitation.
This document provides information about cerebral palsy, including:
(1) It is a motor function disorder caused by permanent brain damage present at birth or shortly after.
(2) The most common types are spastic cerebral palsy (stiff muscles) and athetoid cerebral palsy (uncontrolled movements).
(3) Treatment aims to improve symptoms through physical therapy, bracing, medication, botulinum toxin injections, and sometimes surgery. The goal is improving quality of life and function rather than curing the underlying brain damage.
Outline of presentation
Introduction
Epidemiology
Etiology
Clinical manifestations
Diagnosis
Treatment
INTRODUCTION
Cerebral palsy (CP) refers to a heterogeneous group of conditions involving permanent nonprogressive central motor dysfunction that affect muscle tone, posture, and movement.
These conditions are due to abnormalities of the developing fetal or infantile brain resulting from a variety of causes.
The motor impairment generally results in limitations in functional abilities and activity which can range in severity.
The motor disorders are often accompanied by disturbances of sensation , perception, cognition, communication, and behavior as well as by epilepsy and secondary musculoskeletal problems.
CP has historically been considered a static encephalopathy, but some of the neurologicfeatures of CP, such as movement disorders and orthopedic complications can change or progress over time.
Many children and adults with CP function at a high educational and vocational level,without any sign of cognitive dysfunction
Etiology
CP is caused by a broad group of
Developmental,
Genetic,
Metabolic,
Ischemic,
Infectious, and
Other acquired etiologies
Epidemiology
CP is the most common and costly form of chronic motor disability that begins in childhood
Incidence is 3.6 per 1,000 children with a male: female ratio of 1.4 : 1.
Most children with CP had been born at term with uncomplicated labors anddeliveries
Risk factors
Prematurity and VLBW
Heavy maternal alcohol consumption,
Maternal smoking,
Maternal obesity, and
Infections during pregnancy
In 80% of cases, features were identified pointing to antenatal factors causing abnormal brain development
Fewer than 10% of children with CP had evidence of intrapartum asphyxia
Intrauterine exposure to maternal infection (chorioamnionitis, urinary tract infection) was associated with a significant increase in the risk of CP in normal birthweight infants.
Multiple pregnancy was also associated with a higher incidence of CP
Death of a twin in utero carries an even greater risk of CP
Infertility treatments are also associated with a higher rate of CP
CP is more common and more severe in boys than girls, and this effect is enhanced at the extremes of body weight
Elevated levels of inflammatory cytokines have been reported in heelstick blood collected at birth from children who later were identified with CP.
The prevalence of CP has increased somewhat as a result of the enhanced survival of very premature infants weighing < 1,000 g, who go on to develop CP at a rate of ~ 15 per 100.
However, the GA at birth adjusted prevalence of CP among 2 yr old former premature infants born at 20-27 wk of gestation has decreased over the past decade
The major lesions that contribute to CP in preterm infants are intracerebral hemorrhage and periventricular leukomalacia (PVL).
Neural tube defects are birth defects that result from the failure of the neural tube to close properly during early embryonic development. The most common types are spina bifida, anencephaly, and encephalocele. Prevention focuses on women getting adequate folic acid before and during early pregnancy. Treatment depends on the specific type of defect but may involve surgery to repair the opening and protect the exposed tissues, management of any related conditions like hydrocephalus, and lifelong care for resulting physical, neurological, and functional impairments. Prognosis depends on the severity of the defect and can include permanent disability.
Cerebral palsy assessment and management (PT) case presentation Meet Desai
The document discusses cerebral palsy, its causes, types, and treatment. It defines cerebral palsy as a motor disorder caused by brain damage early in development. The main causes are prenatal (e.g. brain malformations), perinatal (e.g. asphyxia during birth), and postnatal (e.g. infections). The physiotherapy management of cerebral palsy aims to improve mobility and function through techniques like passive stretching, strengthening exercises, and gait training. Treatment is multidisciplinary, involving physicians, surgeons, therapists and other specialists.
Common neonatal disorders include birth injuries, physiological problems, and respiratory, sepsis, and seizure issues. Birth injuries can involve soft tissue, the head, or nerves. Physiological problems include hyperbilirubinemia, hypoglycemia, hypocalcemia, and hypothermia. Respiratory disorders include respiratory distress syndrome and meconium aspiration syndrome. Neonatal jaundice is usually physiological but can also be pathological, breastfeeding-related, or due to breast milk. It is assessed and managed through history, examination, tests, phototherapy or admission based on bilirubin levels.
Cerebral palsy is a non-progressive brain disorder that causes impaired movement and posture. It is caused by damage to the developing brain, most often before or during birth. The document discusses the definition, prevalence, causes, classifications, clinical presentation, treatments, and management of cerebral palsy. It notes that cerebral palsy affects movement, mobility, communication, learning, self-care and more. Treatment involves a multidisciplinary team approach including physicians, physical therapists, occupational therapists and others.
The document contains summaries of 20 OSCE pediatric stations including questions on Down syndrome with esophageal atresia, typhoid vaccination recommendations, hemoglobin disorders, muscular dystrophies, transverse myelitis, Ehlers Danlos syndrome, pulmonary sequestration, Reiter's syndrome, enterobiasis, cleidocranial dysplasia, Wilson's disease, spinal cord injuries, Meckel's scan, congenital hypothyroidism, hemophilia A, neurocysticercosis and their diagnoses and management. The stations cover ethics, clinical examination, choice of investigations, interpretations of tests and forming differential diagnoses.
Cerebral palsy is a motor function disorder caused by a permanent, non-progressive brain lesion that is present at birth or shortly thereafter. It is characterized by impaired muscle coordination and tone. The main types are spastic, athetoid, ataxic, and mixed cerebral palsy. Treatment focuses on rehabilitation, physical therapy, surgery, and assistive devices to improve mobility and function rather than treating the underlying brain damage. The goals are to maximize independence and quality of life.
Cerebra palsy Management - Dr. Ramya -Pediatricspediatricsmgmcri
This document provides an overview of cerebral palsy (CP), including its definition as a non-progressive disorder caused by brain lesions or abnormalities that causes impaired movement and posture. It discusses the history of CP and risk factors like prematurity. The most common type is spastic CP, which can affect limbs differently. Associated problems include intellectual impairment, seizures, feeding and respiratory issues. Diagnosis involves assessing symptoms and medical history. Treatment involves physical, occupational and speech therapy, orthotics, surgery and medications to manage symptoms, along with special education and supportive services.
Cerebral palsy (CP) is divided into four major classifications: spastic, ataxic, dyskinetic, and mixed. The most common type is spastic CP, which is caused by damage to the pyramidal region and results in hypertonia, increased reflexes, and an abnormal gait. CP can be caused prenatally by factors like prematurity or infection, perinatally by hypoxic ischemic encephalopathy or kernicterus, or postnatally by infection or trauma. Diagnosis involves assessing for signs of abnormal muscle tone and movement, as well as investigations like brain imaging. Treatment requires a multidisciplinary approach including management of spasticity, associated issues like seizures
approach to a child with altered sensorium.pptxdrgsvt
The document provides guidance on assessing and managing an altered sensorium in a child. It describes stabilizing the child's airway, breathing, and circulation. It also recommends treating potential causes like hypoglycemia, infections, seizures and raised intracranial pressure. The primary goals are saving the child's life and achieving intact neurological recovery through a multidisciplinary approach.
Cerebral palsy is a permanent neurological disorder caused by non-progressive brain damage early in life. It affects movement and posture. The incidence is about 2 per 1000 live births in developed countries and 7 per 1000 in developing countries. Causes include complications during pregnancy, birth injuries, infections, and genetic factors. Treatment is non-curative and aims to improve function through a multidisciplinary approach including physiotherapy, orthopedic management, medications, assistive devices, and early intervention. Prognosis depends on the type and severity of symptoms present.
Cerebral palsy (CP) is a group of disorders caused by damage to the developing brain either during pregnancy or shortly after birth. It affects movement and posture and can cause physical disability. The main types are spastic CP (stiff muscles), athetoid/dyskinetic CP (uncontrolled movements), and ataxic CP (problems with coordination). Risk factors include preterm birth, low birth weight, infections during pregnancy, complications during delivery, and genetic disorders. Diagnosis involves assessing motor skills, muscle tone, reflexes, and ruling out other potential causes through imaging and tests.
Spinal tuberculosis can lead to serious deformities and neurological deficits if left untreated. It is most commonly caused by hematogenous spread from the lungs. Diagnosis involves clinical history, imaging studies like x-rays and MRI, and laboratory tests. Treatment consists of a combination of chemotherapy for at least 18 months and surgery if indicated to decompress the spinal cord and correct deformities. With early detection and proper management, spinal tuberculosis can be cured with good long-term outcomes.
Cerebral palsy is defined as a group of non-progressive motor impairment syndromes caused by abnormalities in movement, posture and tone. It has various etiologies including prenatal, perinatal and postnatal factors. It is classified based on the type of motor dysfunction into spastic, dyskinetic, hypotonic and ataxic. Diagnosis involves assessing abnormal signs and developmental milestones. Management is multidisciplinary and aims to minimize disability through rehabilitation therapies, prevention of contractures, drug treatments and assistive devices.
This document contains summaries of several pediatric endocrinology case studies presented as multiple choice questions. It discusses the following key points in 3 sentences:
1) A case of a 7-year-old girl with short stature is presented, and bone age assessment is identified as the most appropriate initial diagnostic investigation.
2) An 18-month-old boy with increasing bowing of the legs is described, and Blount's disease, which causes inward bowing of the tibia, is identified as the most likely diagnosis based on the presented x-ray findings.
3) An 8-week-old infant with fractures during birth and eye changes is discussed, and osteogenesis imperfecta, which
The neonatal period involves physiologic adjustments outside the womb. Seizures are common during this time, especially in preterm infants. There are 5 main types of neonatal seizures. Common causes include hypoxic-ischemic encephalopathy, infection, metabolic disturbances, and drugs. Treatment involves identifying the underlying cause, administering anticonvulsants like phenobarbital, and supportive care. Prognosis depends on the etiology, with HIE carrying the highest risk of neurodevelopmental issues.
Monitor indicators of genetic diversity from space using Earth Observation dataSpatial Genetics
Genetic diversity within and among populations is essential for species persistence. While targets and indicators for genetic diversity are captured in the Kunming-Montreal Global Biodiversity Framework, assessing genetic diversity across many species at national and regional scales remains challenging. Parties to the Convention on Biological Diversity (CBD) need accessible tools for reliable and efficient monitoring at relevant scales. Here, we describe how Earth Observation satellites (EO) make essential contributions to enable, accelerate, and improve genetic diversity monitoring and preservation. Specifically, we introduce a workflow integrating EO into existing genetic diversity monitoring strategies and present a set of examples where EO data is or can be integrated to improve assessment, monitoring, and conservation. We describe how available EO data can be integrated in innovative ways to support calculation of the genetic diversity indicators of the GBF monitoring framework and to inform management and monitoring decisions, especially in areas with limited research infrastructure or access. We also describe novel, integrative approaches to improve the indicators that can be implemented with the coming generation of EO data, and new capabilities that will provide unprecedented detail to characterize the changes to Earth’s surface and their implications for biodiversity, on a global scale.
Download the Latest OSHA 10 Answers PDF : oyetrade.comNarendra Jayas
Latest OSHA 10 Test Question and Answers PDF for Construction and General Industry Exam.
Download the full set of 390 MCQ type question and answers - https://www.oyetrade.com/OSHA-10-Answers-2021.php
To Help OSHA 10 trainees to pass their pre-test and post-test we have prepared set of 390 question and answers called OSHA 10 Answers in downloadable PDF format. The OSHA 10 Answers question bank is prepared by our in-house highly experienced safety professionals and trainers. The OSHA 10 Answers document consists of 390 MCQ type question and answers updated for year 2024 exams.
Kinetic studies on malachite green dye adsorption from aqueous solutions by A...Open Access Research Paper
Water polluted by dyestuffs compounds is a global threat to health and the environment; accordingly, we prepared a green novel sorbent chemical and Physical system from an algae, chitosan and chitosan nanoparticle and impregnated with algae with chitosan nanocomposite for the sorption of Malachite green dye from water. The algae with chitosan nanocomposite by a simple method and used as a recyclable and effective adsorbent for the removal of malachite green dye from aqueous solutions. Algae, chitosan, chitosan nanoparticle and algae with chitosan nanocomposite were characterized using different physicochemical methods. The functional groups and chemical compounds found in algae, chitosan, chitosan algae, chitosan nanoparticle, and chitosan nanoparticle with algae were identified using FTIR, SEM, and TGADTA/DTG techniques. The optimal adsorption conditions, different dosages, pH and Temperature the amount of algae with chitosan nanocomposite were determined. At optimized conditions and the batch equilibrium studies more than 99% of the dye was removed. The adsorption process data matched well kinetics showed that the reaction order for dye varied with pseudo-first order and pseudo-second order. Furthermore, the maximum adsorption capacity of the algae with chitosan nanocomposite toward malachite green dye reached as high as 15.5mg/g, respectively. Finally, multiple times reusing of algae with chitosan nanocomposite and removing dye from a real wastewater has made it a promising and attractive option for further practical applications.
The modification of an existing product or the formulation of a new product to fill a newly identified market niche or customer need are both examples of product development. This study generally developed and conducted the formulation of aramang baked products enriched with malunggay conducted by the researchers. Specifically, it answered the acceptability level in terms of taste, texture, flavor, odor, and color also the overall acceptability of enriched aramang baked products. The study used the frequency distribution for evaluators to determine the acceptability of enriched aramang baked products enriched with malunggay. As per sensory evaluation conducted by the researchers, it was proven that aramang baked products enriched with malunggay was acceptable in terms of Odor, Taste, Flavor, Color, and Texture. Based on the results of sensory evaluation of enriched aramang baked products proven that three (3) treatments were all highly acceptable in terms of variable Odor, Taste, Flavor, Color and Textures conducted by the researchers.
Earth Day How has technology changed our life?
Thinkers/Inquiry • How has our ability to think and inquire helped to advance technology?
Vocabulary • Nature Deficit Disorder~ A condition that some people maintain is a spreading affliction especially affecting youth but also their adult counterparts, characterized by an excessive lack of familiarity with the outdoors and the natural world. • Precautionary Principle~ The approach whereby any possible risk associated with the introduction of a new technology is largely avoided, until a full understanding of its impact on health, environment and other areas is available.
What is technology? • Brainstorm a list of technology that you use everyday that your parents or grandparents did not have. • Compare your list with a partner.
Evolving Lifecycles with High Resolution Site Characterization (HRSC) and 3-D...Joshua Orris
The incorporation of a 3DCSM and completion of HRSC provided a tool for enhanced, data-driven, decisions to support a change in remediation closure strategies. Currently, an approved pilot study has been obtained to shut-down the remediation systems (ISCO, P&T) and conduct a hydraulic study under non-pumping conditions. A separate micro-biological bench scale treatability study was competed that yielded positive results for an emerging innovative technology. As a result, a field pilot study has commenced with results expected in nine-twelve months. With the results of the hydraulic study, field pilot studies and an updated risk assessment leading site monitoring optimization cost lifecycle savings upwards of $15MM towards an alternatively evolved best available technology remediation closure strategy.
2. Definition:
Static Encephalopathy of motor & / or
posture due to an insult to the developing
brain in the 1st two years of life. It consist of
motor handicap & non-motor handicap.
3. Cerebral Palsy
• Key findings in history and physical examination
– History:
• Prematurity
• Light-for-date
• APGAR score
• Blood group incompatibility
• Jaundice
• Respirator or oxygen needed at birth
• The child favors one hand
• A history of neurological infection
• The child has had a seizure
• Any other major illness during the first month of life
4. Cerebral Palsy
• Key Findings Continued:
– Examination
• Persistent automatisms
• Spasticity (Increased muscle tone, hyperactive
reflexes, Babinski response)
• Hypotonia (during the first year of life only)
• Asymmetry of limb development, especially nails
• Disordered movement
• Congenital abnormalities
• Strabismus
• Changes to normal head growth
• Delayed developmental milestones
5. What causes Cerebral Palsy?
• Illness during pregnancy
• Premature delivery
• Accidents such as falling, car crash
• Lead poisoning
• Viral infections
• Lack of oxygen or blood reaching the
newborns brain
6. Causes & Incidence
• Radiation exposure, infection, or use of certain
drugs during 1st 3 months of pregnancy, or
chromosome abnormalities.
• Damage in later stages of pregnancy.
• Birth complications.
• Neo-natal complications
• Incidence is approximately 1 in 500 with the
incidence of boys being affected 30% higher
than girls
7. characteristic features of the disease:
b. Non-motor handicap (≥ 1).
65% speech defect.
50% mental retardation (spastic quariplegia)
50% ocular defect (squint, nystagmus,
refractive error)
40% epilepsy (spastic hemiplegia)
25% hearing defect..
20% frequent dental caries
20% inability to chew.
20% inability to swallow easily.
8. Other associated abnormalities:
• Malocclusion.
• Enamel defect
• GER.
• Drooling of saliva (defective swallowing).
• Constipation.
• Incontinence.
• Recurrent infection.
• Failure to thrive.
The non - motor handicap may be more
important than the motor ones.
9. Prevalence of cerebral palsy:
● 3/1000 to 9/10,000 new babies each year
● During past 3 decades considerable
advances made in obstetric & neonatal
care does not changes prevelance of CP
11. Classification:
A. Etiological:
i) Prenatal
ii) Natal
iii) Postnatal
B. Topographical:
i. Monoplegic.
ii. Paraplegic.
iii. Triplegic.
iv. Quadriplegic
v. Diplegic.
vi. Hemiplegic.
vii. Double hemiplegic.
12. C. Physiological:
i. Spastic CP.
ii. Dyskinetic CP.
iii. Ataxic CP.
iv. Atonic CP.
v. Rigid CP
D. Functional:
i. Class I: no limitation to physical activity.
ii. Class II: mild limitation to physical activity.
iii. Class III: moderate limitation to activity.
iv. Class IV: sever (no useful physical activity).
13. A. Etiological classification:
● Most cases = unknown etiology.
● Improvement in perinatal care has little
impact on incidence of CP.
17. ● Risk factors for CP:
– Consanguinity.
– Mother with long menstrual cycle.
– History of spontaneous abortion/stillbirth.
– Family history of CP.
– Malpresentation.
– Low socioeconomic status.
21. Spasticity is the commonest affection
of the involved limb.
1. Spastic quadriplegia :
all 4 limbs are equally involved.
2. Spastic diplegia :
all 4 limbs affected with lower more
involved
3. Spastic double hemiplegia:
all 4 limbs affected with upper more
involved.
4. Spastic hemiplegia:
one side of affected with upper more involved.
22. 1. Spastic quadriplegia (27% - CP):
● Most severe form of CP.
● IQ: severe Mental retardation.
● Seizures very frequent.
● Pathology : cystic cavitations of central white
matter of brain.
● Clinical feature:
i) Severe spasticity of all 4 limbs+signs of UMNL
i) Flexion contracture of knee and elbow
( characteristic).
iii) Associated disabillities - speech, vision and
swallowing disorders, athetosis
23. 2. Spastic hemiplegia (21%-CP):
● 25% are mentally retarded.
● 30% have seizure by 2nd year.
● Aetiology : intrauterine thromboembolism
● Pathology: revealed by CT-scan/MRI :
– Atrophy of cerebral hemisphere on contra lateral
side.
– Dilation of lateral ventricle on the affected side.
24. Clinical feature:
– One side affected (spastic – weak ).
– Upper limb more affected than lower
– Decreased spontaneous movement on affected
side .
– Delayed walking (18 – 24).
– Abnormal gait (circumduction).
– Dystonic posture of UL in running.
– UL: Adduction at shoulder, flexion at elbow
and wrist joints.
– LL: Abduction at hip, extention at knee and ankle
joints.
– Equinovarus deformity of affected LL.
– Increased DTR. Clonus, +ve babiniski sign.
25. 3. Spastic diplegia (21% -CP):
● IQ : excellent.
● Seizure : less frequent.
● Etiology :common factor is prematurity.
● Pathology: periventricular leukomalacia.
26. Clinical feature:
Prominant spasticity of LL + signs of UMNL.
Difficulty in application of diaper (early
symptom).
Commando crawl.
Maintained scissoring of LL when suspended
from axilla.
Walking: delayed, tip toe .
Disuse atrophy of LL.
27. Athetoid CP:
● IQ: preserved in most patient.
● seizure: uncommon.
● etiology: hyperbilirubinemia (neonatal
period).
● athetosis main clinical feature.
(athetosis=uncontrollable writhing
movements at distal extremities ).
● involves all four extremities
● Neck and face may be involved
● Voluntary movements are flailing
● Difficulty up righting and balancing
29. ● Ataxic CP:
- Broad based gait (unsteady gait with
feet far apart).
- Affects balance and coordination.
- Difficulty with motions requiring
precise coordination such as writing.
30. ● Dyskinetic CP:
- all 4 limbs are affected.
- abnormal movement.
- movement is chorioathetoid or
dystonic.
chorioathetoid movement
31.
32.
33. D. Functional classification:
● class I: no limitation to physical activity.
● class II: mild limitation to physical activity.
● class III: moderate limitation to activity.
● class IV: severe (no useful physical activity).
34. Differential diagnosis of CP:
1. Neurodegenerative disorders:
Initial normal and subsequent slowing of
milestones.
Loss of previously attained milestones.
Unusual body odour.
+ve family history.
Hypotonia without hyperreflexia.
Primary ataxia.
2. spinal cord lesions.
3. myopathy.
4. primary mental retardation.
36. important points in history:
- Pregnancy: prematurity, maternal diseases
(uncontrolled diabetes, maternal
hypertention)
- Delivery: emergency C/S.
syntocinon – 1st stage of labour.
prolonged rupture of menmbrane.
prolonged 2nd stage of labour.
- After birth: prematurity signs/ small size baby
delayed weak cry, delayed poor suckling,
hyperbilirubinrmia, neonatal seizers, RDS
37. Investigations:
● Diagnosis is mainly clinical.
● Investigations for underling pathology
e.g : CT, MRI of brain.
or when other differential is possible.
● Relevant investigations include:
a. TORCH screen.
b. Urine for metabolic screening.
c. Chromosomal analysis.
38. Management of CP
Goals of management:
1. improve preserved functions.
2. develop compensatory functions.
3. encourage independence.
4. maintain normal growth.
5. facilitate communocation.
6. insure good dental hygiene
------------------- REHABILITATION
40. REHABILITATION:
● Team management:
o Pediatric neurologist.
o Physiotherapiest.
o Occupational therapist.
o Orthopedic/neuro surgeon.
o Speech therapist.
o Social workers.
o Nutritionist.
42. b) Nutritional care:
• Regular follow up of weight.
• Gastric tube (home).
• Nasogastric tupe (hospital).
c) Hearing care:
Assessment and treatment of hearing deficit
Mild deficit: 24 – 45 db loss=no intervention
Mod. deficit: 45-65 db loss=hearing aids.
Sever deficit: 65-85 db loss= amplification.
Profound deficit:>85 db loss= special
education for deaf
43. d) Vision care:
Use of spectacles.
Surgical correction of squint.
e) Dental care:
• Evaluate ability to clean
• Highlight importance to parents.
• Modified toothbrush.
• Fluoride
• Non non-carious food.
44. f) Physiotherapy:
Most important care especially for
spastic CP
Maintain maximum range of joints
movement to attain at least daily activity
e.g: combing hair, brushing teeth,
bathing, toilet, dressing, driving specially
reformed vehicles.
>>>>> insure dependency.
45. g) Surgical procedures:
• Contractures
• Spasticity not responding to drugs.
• Deformity
• Severe scoliolsis.
h) Social and economical support :
Friendship societies, health insurance…etc)